Sordoillet C, Chauvin M A, de Peretti E, Morera A M, Benahmed M
INSERM CJF no. 90-08, Laboratoire de Biochimie, Hôpital Sainte-Eugénie, Pierre-Bénite, France.
Endocrinology. 1991 Apr;128(4):2160-8. doi: 10.1210/endo-128-4-2160.
The actions and the mechanisms of action of epidermal growth factor (EGF) in testicular steroidogenesis were investigated using a model of primary culture of purified porcine Leydig cells from immature intact animals. EGF decreased (1.7-fold) human CG (hCG)-induced dehydroepiandrosterone (DHEA) accumulation in the medium whereas it enhanced (2.5-fold) that of testosterone. The maximal and half-maximal effects on both DHEA and testosterone secretions were observed at similar concentrations which were, respectively, 3 (5 x 10(-10) M) and 0.7 (11 x 10(-11) M) ng/ml EGF, after 72-h treatment. EGF effect on DHEA and testosterone secretion was similarly observed whether the cells were acutely (3 h) stimulated with hCG (1 ng/ml) or with 8-bromo-cAMP (10(-3) M). To further localize the steroidogenic biochemical steps affected by EGF, the growth factor action on steroidogenic enzyme activities was investigated. EGF increased delta 5 steroid intermediate (i.e. pregnenolone and DHEA) formation [evaluated in the presence of 10(-5) M of WIN 24540, an inhibitor of 3 beta-hydroxysteroid dehydrogenase/iosomerase (3 beta-HSDI) activity]. However, this stimulation was observed in cells when acutely (3 h) stimulated with hCG (0.01-1 ng/ml) but not when incubated with 22R-hydroxycholesterol (0.01-10 micrograms/ml). Such findings indicate that EGF did not affect cholesterol side chain cleavage cytochrome P450 activity but probably increased cholesterol substrate availability for this enzyme in the inner mitochondria. Moreover, EGF significantly (P less than 0.001) increased delta 5 steroid intermediate (i.e. pregnenolone and DHEA) but not delta 4 steroid intermediate (i.e. progesterone and androstenedione) conversion into testosterone, indicating that EGF enhances 3 beta-HSDI activity. Such effects of EGF are directly exerted on Leydig cells since EGF receptors (Kd = 16 x 10(-11) M) are present in primary cultures of purified porcine Leydig cells. Together, the present findings show that in Leydig cells from intact animals, EGF enhances the gonadotropin action on testosterone formation through an increase in the availability of cholesterol substrate in the mitochondria as well as an increase in the activity of 3 beta-HSDI.
利用来自未成熟完整动物的纯化猪睾丸间质细胞原代培养模型,研究了表皮生长因子(EGF)在睾丸类固醇生成中的作用及作用机制。EGF使培养基中促性腺激素释放激素(hCG)诱导的脱氢表雄酮(DHEA)积累减少(1.7倍),而使睾酮积累增加(2.5倍)。在72小时处理后,对DHEA和睾酮分泌的最大和半最大效应在相似浓度下观察到,分别为3(5×10⁻¹⁰M)和0.7(11×10⁻¹¹M)ng/ml EGF。无论细胞是用hCG(1 ng/ml)还是8-溴环磷腺苷(10⁻³M)急性刺激(3小时),都观察到EGF对DHEA和睾酮分泌的类似作用。为了进一步定位受EGF影响的类固醇生成生化步骤,研究了生长因子对类固醇生成酶活性的作用。EGF增加了δ⁵类固醇中间体(即孕烯醇酮和DHEA)的形成[在存在10⁻⁵M的WIN 24540(一种3β-羟基类固醇脱氢酶/异构酶(3β-HSDI)活性抑制剂)的情况下评估]。然而,这种刺激在细胞用hCG(0.01 - 1 ng/ml)急性刺激(3小时)时观察到,但在用22R-羟基胆固醇(0.01 - 10微克/毫升)孵育时未观察到。这些发现表明,EGF不影响胆固醇侧链裂解细胞色素P450活性,但可能增加了该酶在内质网中胆固醇底物的可用性。此外,EGF显著(P<0.001)增加了δ⁵类固醇中间体(即孕烯醇酮和DHEA)但未增加δ⁴类固醇中间体(即孕酮和雄烯二酮)向睾酮的转化,表明EGF增强了3β-HSDI活性。EGF的这种作用直接作用于睾丸间质细胞,因为在纯化猪睾丸间质细胞的原代培养物中存在EGF受体(Kd = 16×10⁻¹¹M)。总之,目前的研究结果表明,在完整动物的睾丸间质细胞中,EGF通过增加线粒体中胆固醇底物的可用性以及3β-HSDI的活性,增强了促性腺激素对睾酮形成的作用。